Form 4: Surmodics CEO Gary Maharaj Sells Shares to Cover Tax Obligations

Surmodics CEO Gary Maharaj sold 4,248 shares of common stock to cover tax obligations related to vesting of shares.

Summary

• Gary Maharaj, the President and CEO of Surmodics Inc., sold 4,248 shares of common stock on December 4, 2024.
• The sale was executed at a price of $39.91 per share.
• This transaction was to cover tax obligations related to the vesting of shares.
• Following the transaction, Mr. Maharaj directly owns 192,056 shares of Surmodics common stock.

Sentiment

Score: 5

Explanation: The document is a routine Form 4 filing, indicating a standard transaction for tax purposes. It does not suggest any positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing is typical for executives who sell shares to cover tax obligations related to stock awards.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are common across publicly traded companies.
• The sale by Gary Maharaj is consistent with standard practices for executives who receive equity compensation.
• Similar filings are regularly made by executives at comparable companies in the medical device industry.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant given the routine nature of the transaction.

Key Dates

Keywords

Surmodics, Gary Maharaj, stock sale, insider trading, Form 4, executive compensation, tax obligations